The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA3 Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition

被引:37
作者
Cheong, Siew Lee [2 ]
Dolzhenko, Anna [2 ]
Katchler, Sonja [3 ]
Paoletta, Silvia [1 ]
Federico, Stephanie [4 ]
Cacciari, Barbara [5 ]
Dolzhenko, Anton [2 ]
Klotz, Karl-Norbert [3 ]
Moro, Stefano [1 ]
Spalluto, Giampiero [4 ]
Pastorin, Giorgia [2 ]
机构
[1] Univ Padua, Dipartimento Sci Farmaceut, MMS, I-35131 Padua, Italy
[2] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
[3] Univ Wurzburg, Inst Pharmakol, D-97078 Wurzburg, Germany
[4] Univ Trieste, Dipartimento Sci Farmaceut, I-34127 Trieste, Italy
[5] Univ Ferrara, Dipartimento Sci Farmaceut, I-44100 Ferrara, Italy
基金
英国医学研究理事会;
关键词
SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTORS; HUMAN A(3); LIGAND RECOGNITION; PHARMACOLOGICAL EVALUATION; DERIVATIVES; A(2A); SUBTYPES; RESIDUES; CELLS;
D O I
10.1021/jm100049f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Among the heterocyclic structures identified as potent human A(3) (hA(3)) adenosine receptor's antagonists, we have demonstrated that the new pyrazolo-triazolo-pyrimidines, bearing an aryl group in replacement of the C-2-furyl ring, not only confer a good pharmacological profile (with significantly enhanced selectivity against other adenosine receptor subytpes) but also overcome the metabolic transformation of the furan ring into toxic intermediates. All the synthesized [2-(para-substituted) phenyl]-pyrazolo-triazolo-pyrimidines showed affinity at the hA(3) receptor in the low nanomolar range. The most potent derivative of the series presented better affinity and excellent selectivity (compound 31, K-i hA(3) = 0.108 nM; hA(1)/hA(3) = 5200; hA(2A)/hA(3) = 7200), in comparison to the C-2-furyl counterpart. A receptor-driven molecular modeling investigation, based on a recently proposed model of A(3) receptor derived from the crystallographic structure of human A(2A) receptor, has been carried out in order to support the experimental binding data and to justify the enhanced selectivity against the other receptor subtypes.
引用
收藏
页码:3361 / 3375
页数:15
相关论文
共 43 条
[1]  
[Anonymous], MOE MOL OP ENV VERS
[2]  
Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
[3]   Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A3 adenosine receptor antagonists:: Influence of the chain at the N8 pyrazole nitrogen [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Spalluto, G ;
Moro, S ;
Klotz, KN ;
Leung, E ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4768-4780
[4]   Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A2A and A3 adenosine receptors antagonists [J].
Baraldi, PG ;
Fruttarolo, F ;
Tabrizi, MA ;
Preti, D ;
Romagnoli, R ;
El-Kashef, H ;
Moorman, A ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) :1229-1241
[5]   New strategies for the synthesis of A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Bovero, A ;
Fruttarolo, F ;
Romagnoli, R ;
Tabrizi, MA ;
Preti, D ;
Varani, K ;
Borea, PA ;
Moorman, AR .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (19) :4161-4169
[6]   Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: A possible template for adenosine receptor subtypes? [J].
Baraldi, PG ;
Cacciari, B ;
Borea, PA ;
Varani, K ;
Pastorin, G ;
Da Ros, T ;
Tabrizi, MA ;
Fruttarolo, F ;
Spalluto, G .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (26) :2299-2332
[7]   Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor ligands:: A starting point for searching A2B adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Romagnoli, R ;
Klotz, KN ;
Spalluto, G ;
Varani, K ;
Gessi, S ;
Merighi, S ;
Borea, PA .
DRUG DEVELOPMENT RESEARCH, 2001, 53 (2-3) :225-235
[8]   Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A3 adenosine receptor antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Moro, S ;
Spalluto, G ;
Pastorin, G ;
Da Ros, T ;
Klotz, KN ;
Varani, K ;
Gessi, S ;
Borea, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :770-780
[9]   Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A(2A) adenosine antagonists [J].
Baraldi, PG ;
Cacciari, B ;
Spalluto, G ;
Villatoro, MJPDIY ;
Zocchi, C ;
Dionisotti, S ;
Ongini, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) :1164-1171
[10]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3